← Eichor
Study identifier: NCT05316571 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sitting Interruption and Whole-body Cardiovascular Health

Condition: Sedentary Behavior · Sedentary Time  ·  Sponsor: University of North Carolina, Chapel Hill

PhaseNA
Planned participants56
Who can joinAll sexes, 30 Years to 60 Years
Healthy volunteersYes

About this study

There is strong evidence for the association between sedentary behaviors and cardiovascular diseases such as coronary heart disease and stroke. However, the public currently has no clear guidance on how to limit or interrupt their sedentary behaviors. This study will identify and test the physiological effects of several sedentary behavior interruption strategies and explore the feasibility (i.e., likelihood of an individual performing the requested activities) of those strategies to inform the development of public policy surrounding sedentary behavior interruption. Long-term, the findings of this study will inform a large clinical trial that can test whether sedentary behavior reduction can decrease cardiovascular disease risk.

This description comes directly from the study's public registry record.

Talk to the study team

Erik Hanson, PhD  ·  9199620816  ·  switchstudy@unc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of North Carolina at Chapel HillChapel Hill, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05316571